Management of acute stroke in patients taking novel oral anticoagulants

Wiley: 2 JUN 2014

 

Funding: Professor Thorsten Steiner has received honoraria from Boehringer, Bayer, and BMS–Pfizer. Professor Bo Norrving has acted as consultant for Bayer HealthCare, Servier, Syngis, Daichii Sankyo and Allergan, and has received royalties for a book published by Karolinska University Press. Professor Graeme Hankey has received honoraria for serving on the executive committees of the AMADEUS trial (Sanofi-Aventis), ROCKET AF trial (Johnson & Johnson), and the BOREALIS trial (Sanofi-Aventis), and the stroke outcome adjudication committee of the RE–LY and AVERROES trials. He has also received honoraria from Bayer, Boehringer Ingelheim, and Pfizer Australia for speaking at sponsored scientific symposia and consulting on advisory boards. Professor Werner Hacke has received honoraria from Bayer Schering for his role on the ROCKET AF executive committee, and for contributions to educational symposia and participation in advisory boards. He also receives honoraria for participation on advisory boards organized by Daiichi Sankyo. Read More